Coverart for item
The Resource Nanotechnology in diagnosis, treatment and prophylaxis of infectious diseases, edited by Mahendra Rai, Kateryna Kon, (electronic book)

Nanotechnology in diagnosis, treatment and prophylaxis of infectious diseases, edited by Mahendra Rai, Kateryna Kon, (electronic book)

Label
Nanotechnology in diagnosis, treatment and prophylaxis of infectious diseases
Title
Nanotechnology in diagnosis, treatment and prophylaxis of infectious diseases
Statement of responsibility
edited by Mahendra Rai, Kateryna Kon
Contributor
Editor
Subject
Language
eng
Cataloging source
N$T
Dewey number
616.90475
Illustrations
illustrations
Index
index present
LC call number
RC113.3
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
http://library.link/vocab/relatedWorkOrContributorName
  • Rai, Mahendra
  • Kon, Kateryna Volodymyrivna
http://library.link/vocab/subjectName
  • Communicable diseases
  • Communicable diseases
  • Nanomedicine
  • Nanotechnology
  • Communicable Disease Control
  • Communicable Diseases
  • Communicable Diseases
  • Drug Resistance, Microbial
  • Antibiotics
  • Bacterial diseases -- Chemotherapy
  • Nanomedicine
Label
Nanotechnology in diagnosis, treatment and prophylaxis of infectious diseases, edited by Mahendra Rai, Kateryna Kon, (electronic book)
Instantiates
Publication
Bibliography note
Includes bibliographical references and index
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Color
multicolored
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
  • Front Cover; Nanotechnology in Diagnosis, Treatment and Prophylaxis of Infectious Diseases; Copyright Page; Contents; List of Contributors; Preface; 1 Gold and Silver Nanoparticles for Diagnostics of Infection; 1.1 Nanotechnology and Infection; 1.2 Gold and Silver NPs for Molecular Diagnostics; 1.2.1 Biomarkers; 1.3 Nanodiagnostics for Nucleic Acids; 1.3.1 Homogeneous Colorimetric Assays; 1.3.1.1 Unmodified NPs; 1.3.1.2 Cross-Linking; 1.3.1.3 Noncross-Linking; 1.3.2 Heterogeneous Detection; 1.3.2.1 Microarrays; 1.3.2.2 Lateral Flow Assays; 1.3.3 Electrochemical Assays
  • 1.3.4 Fluorescence Assays1.3.5 Raman and SERS; 1.3.6 Other; 1.4 Aptamers and Antibodies; 1.4.1 Colorimetric; 1.4.2 Electrochemical; 1.4.3 Lateral Flow Assays; 1.5 iPCR and Other Methods; 1.6 Conclusion; References; 2 Antimicrobial Models in Nanotechnology: From the Selection to Application in the Control and Treatment of Infectious Diseases; 2.1 Introduction; 2.2 Antimicrobial Susceptibility Testing Methods of NMs; 2.2.1 Broth Dilution Test; 2.2.2 Spectrophotometric Measurement; 2.2.3 Cell Counting; 2.2.4 Colorimetric and Fluorescent Assays; 2.2.5 In Vitro Infection Animal Model
  • 2.2.6 Biocidal Testing2.2.7 Antibiofilm Activity; 2.2.8 Quorum-Sensing Inhibitors; 2.2.9 Microbial Membrane Lysis; 2.2.10 Microbial Oxidative Stress; 2.2.11 Antipersister and Antidormancy Bacterial Cells; 2.2.12 Microbial Fitness; 2.3 Nanotoxicology; 2.3.1 Nano-Genotoxicology; 2.3.2 Cytotoxicity; 2.3.3 Immunotoxicity; 2.3.4 In Vitro Skin Irritation; 2.3.5 Caenorhabditis elegans Toxicity Model; 2.3.6 Nanotoxicity in Embryonic and Adult Zebrafish; 2.3.7 Bioluminescence-Based Nanotoxicity Test; 2.4 In Vitro Pharmacokinetics/Pharmacodynamic Models; 2.4.1 Particokinetics; 2.4.2 Caco-2 Permeability
  • 2.4.3 Hollow Fiber System2.5 Conclusions; References; 3 Silver Nanoparticles for the Control of Vector-Borne Infections; 3.1 Introduction; 3.2 Louse-Borne Infections and Activity of AgNPs Against Lice; 3.3 Mosquito-Borne Infections and Activity of AgNPs Against Mosquitoes; 3.4 Tick-Borne Infections and Activity of AgNPs Against Ticks; 3.5 Flies, Their Role in Transmission and Spread of Infections, and Activity of AgNPs Against Flies; 3.6 Conclusions and Future Prospects; References; 4 Magnetite Nanostructures: Trends in Anti-Infectious Therapy; 4.1 Introduction
  • 4.2 Nanoparticles with Biomedical Applications4.2.1 Design of Tailored Magnetic Nanoparticles with Applications in Microbiology; 4.2.2 Magnetite Nanoparticles Used to Control Microorganisms Attachment and Biofilm Formation; 4.2.3 The Biocompatibility of Magnetite Nanoparticles; 4.2.3.1 Biocompatibility Evaluation of Magnetite Nanoparticles at the Cellular Level; 4.2.3.2 Biocompatibility Evaluation of Magnetite Nanoparticles at Biochemical and Molecular Level; 4.2.3.3 Biocompatibility Evaluation of Magnetite Nanoparticles Using Animal Models; 4.3 Conclusions; References
Control code
SCIDI910159094
Dimensions
unknown
Extent
1 online resource
File format
unknown
Form of item
online
Isbn
9780128014714
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Other physical details
illustrations (some color)
Reformatting quality
preservation
Sound
unknown sound
Specific material designation
remote
Label
Nanotechnology in diagnosis, treatment and prophylaxis of infectious diseases, edited by Mahendra Rai, Kateryna Kon, (electronic book)
Publication
Bibliography note
Includes bibliographical references and index
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Color
multicolored
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
  • Front Cover; Nanotechnology in Diagnosis, Treatment and Prophylaxis of Infectious Diseases; Copyright Page; Contents; List of Contributors; Preface; 1 Gold and Silver Nanoparticles for Diagnostics of Infection; 1.1 Nanotechnology and Infection; 1.2 Gold and Silver NPs for Molecular Diagnostics; 1.2.1 Biomarkers; 1.3 Nanodiagnostics for Nucleic Acids; 1.3.1 Homogeneous Colorimetric Assays; 1.3.1.1 Unmodified NPs; 1.3.1.2 Cross-Linking; 1.3.1.3 Noncross-Linking; 1.3.2 Heterogeneous Detection; 1.3.2.1 Microarrays; 1.3.2.2 Lateral Flow Assays; 1.3.3 Electrochemical Assays
  • 1.3.4 Fluorescence Assays1.3.5 Raman and SERS; 1.3.6 Other; 1.4 Aptamers and Antibodies; 1.4.1 Colorimetric; 1.4.2 Electrochemical; 1.4.3 Lateral Flow Assays; 1.5 iPCR and Other Methods; 1.6 Conclusion; References; 2 Antimicrobial Models in Nanotechnology: From the Selection to Application in the Control and Treatment of Infectious Diseases; 2.1 Introduction; 2.2 Antimicrobial Susceptibility Testing Methods of NMs; 2.2.1 Broth Dilution Test; 2.2.2 Spectrophotometric Measurement; 2.2.3 Cell Counting; 2.2.4 Colorimetric and Fluorescent Assays; 2.2.5 In Vitro Infection Animal Model
  • 2.2.6 Biocidal Testing2.2.7 Antibiofilm Activity; 2.2.8 Quorum-Sensing Inhibitors; 2.2.9 Microbial Membrane Lysis; 2.2.10 Microbial Oxidative Stress; 2.2.11 Antipersister and Antidormancy Bacterial Cells; 2.2.12 Microbial Fitness; 2.3 Nanotoxicology; 2.3.1 Nano-Genotoxicology; 2.3.2 Cytotoxicity; 2.3.3 Immunotoxicity; 2.3.4 In Vitro Skin Irritation; 2.3.5 Caenorhabditis elegans Toxicity Model; 2.3.6 Nanotoxicity in Embryonic and Adult Zebrafish; 2.3.7 Bioluminescence-Based Nanotoxicity Test; 2.4 In Vitro Pharmacokinetics/Pharmacodynamic Models; 2.4.1 Particokinetics; 2.4.2 Caco-2 Permeability
  • 2.4.3 Hollow Fiber System2.5 Conclusions; References; 3 Silver Nanoparticles for the Control of Vector-Borne Infections; 3.1 Introduction; 3.2 Louse-Borne Infections and Activity of AgNPs Against Lice; 3.3 Mosquito-Borne Infections and Activity of AgNPs Against Mosquitoes; 3.4 Tick-Borne Infections and Activity of AgNPs Against Ticks; 3.5 Flies, Their Role in Transmission and Spread of Infections, and Activity of AgNPs Against Flies; 3.6 Conclusions and Future Prospects; References; 4 Magnetite Nanostructures: Trends in Anti-Infectious Therapy; 4.1 Introduction
  • 4.2 Nanoparticles with Biomedical Applications4.2.1 Design of Tailored Magnetic Nanoparticles with Applications in Microbiology; 4.2.2 Magnetite Nanoparticles Used to Control Microorganisms Attachment and Biofilm Formation; 4.2.3 The Biocompatibility of Magnetite Nanoparticles; 4.2.3.1 Biocompatibility Evaluation of Magnetite Nanoparticles at the Cellular Level; 4.2.3.2 Biocompatibility Evaluation of Magnetite Nanoparticles at Biochemical and Molecular Level; 4.2.3.3 Biocompatibility Evaluation of Magnetite Nanoparticles Using Animal Models; 4.3 Conclusions; References
Control code
SCIDI910159094
Dimensions
unknown
Extent
1 online resource
File format
unknown
Form of item
online
Isbn
9780128014714
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Other physical details
illustrations (some color)
Reformatting quality
preservation
Sound
unknown sound
Specific material designation
remote

Library Locations

Processing Feedback ...